Noncirrhotic portal hypertension due to peripheral T-cell lymphoma, not otherwise specified: A case report

Table 3 A summary of demographic, radiographic, and clinical information from a review of five previously published cases of T-cell lymphomas with ascites and/or portal hypertension manifestations

Ref.	Age, Gender	Course of disease	Clinical Symptoms	Supplementary Examination	Biopsy Source	Immunohistochemistry	Diagnosis	Invasion of other parts	Treatment	Prognosis
Ameri[13]	61, F	2+W	Abdominal discomfort	Ascites, hepatosplenomegaly	Ascites	CD4(+), CD2(+), CD5(+), CD3(+), CD7(-), CD16(-), CD56(-), CD57(-), TdT(-)	PTCL, NOS	Bone marrow	No treatment	NA
Yamamoto[10]	72, W	3+W	Abdominal discomfort	Hydrothorax and ascites	Ascites	CD2 (+), CD3(+) (+),CD45(+), CD4 (–), CD8 (–)	PTCL	Thorax and abdomen	Cyclophosphamide, mitoxantrone, vincristine, etoposide, bleomycin, and prednisolone	Died of multiple organ failure
Izban[12]	76, F		Abdominal tenderness	Ascites, splenomegaly	Ascites	CD2(+), CD3(+), CD5(+), CD7(+), CD45(+), CD4(-), CD8(-)	PTCL	Bone marrow, liver	CHOP chemotherapy	Recurrence after chemotherapy
VakarLópez[11]	49, W	3+M	Abdominal tenderness	Ascites	Ascites	CD3(+)	PTCL, NOS		No treatment	NA
Lindor[9]	65, F	2+Y	Pectoralgia, esophageal and gastric variceal bleeding (EGVB)	Splenomegaly, EGVB	spleen	NA	Diffuse mixed-type T-cell lymphoma		Splenectomy	Bone marrow infiltration occurred 1 + year after the operation

PTCL: Peripheral T-cell lymphoma; NOS: Not otherwise specified.